InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.12
(
0.11%
)
Bitcoin
63,245.37
(
0.14%
)
Post# of 252311
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: jmarce post# 218014

Friday, 03/23/2018 10:30:53 AM

Friday, March 23, 2018 10:30:53 AM

Post# of 252311
They are on retailroadshow now and show is Unum Therapeutics

https://www.retailroadshow.com/

Thanks for pointing out the valuation comp to Gene Editing companies (I don't really follow that area). Not sure how I see them since they are both. Seeing that they have over 100m in cash already the EV (at say $15 IPO) would be about 300m so not quite as bad but still, they are preclinical and I don't like their lead programs in both Gene Editing and Gene Therapy are in PKU (too competitive).
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up